InvestorsHub Logo
Followers 3
Posts 217
Boards Moderated 0
Alias Born 10/16/2010

Re: None

Monday, 11/30/2015 8:46:59 AM

Monday, November 30, 2015 8:46:59 AM

Post# of 34601
JACKSONVILLE, Florida, November 30, 2015 /PRNewswire/ --

TapImmune, Inc. (TPIV), a clinical-stage onco-immunology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, today announced it will be presenting at the 8th Annual LD Micro Main Event on December 1, 2015 at 2.30 PM PT. Dr. John N. Bonfiglio a TapImmune Board member and Strategic Advisor will be giving the presentation and will join TapImmune management in meeting with investors.

The conference will be held at the Luxe Sunset Bel Air Hotel, Los Angeles, CA, and will feature 210 companies in the small/micro-cap space. To view a webcast of the presentation please visit:

http://wsw.com/webcast/ldmicro9/tpiv


http://finance.yahoo.com/news/tapimmune-present-ld-micro-main-133000971.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News